Spine News and Research

RSS

Endoscopic surgery reduces postoperative discomfort and recovery time

Endoscopic surgery has steadily gained in popularity since it was developed in the 1980s. Dr. Richard Siegfried has teamed with Dr. Louis Quartararo one of only a handful of surgeons who have been trained to perform endoscopic surgery on the spine.

14 Oct 2009

FONAR sells two more UPRIGHT Multi-Position MRI scanners

FONAR Corporation announced today two recent sales of its UPRIGHT® Multi-Position™ MRI scanners. Both sales were to private medical practices that choose to remain anonymous for competitive reasons.

13 Oct 2009

Johnson & Johnson announces financial results for the third quarter of 2009

Johnson & Johnson today announced sales of $15.1 billion for the third quarter of 2009, a decrease of 5.3% as compared to the third quarter of 2008. Operational results declined 2.8% and the negative impact of currency was 2.5%. Domestic sales declined 8.1%, while international sales declined 2.5%, reflecting operational growth of 2.4% and a negative currency impact of 4.9%.

13 Oct 2009

SANUWAVE presents findings on extracorporeal shock wave stimulation of osteoprogenitor cells

SANUWAVE, Inc., an emerging medical technology company focused on the development and commercialization of non-invasive, biological response activating devices in the regenerative medicine area, reported that scientific findings titled “Extracorporeal Shock Wave Stimulation of Osteoprogenitor Cells” were presented at the 2009 International Bone-Tissue-Engineering Congress (“Bone-Tec”) in Hannover, Germany, which was held October 9-11, 2009.

13 Oct 2009

FDA clears RSB Spine's Interplate C-Ti as an anterior cervical plate

RSB Spine, LLC, today announced that the InterPlate® C-Ti has been cleared for a new indication. When reclassification of interbody fusion devices occurred in 2007, the C-Ti was the first system cleared by the U.S. Food and Drug Administration. With this most recent announcement, the C-Ti has now become the first interbody fusion device to be cleared as an anterior cervical plate as well.

12 Oct 2009

Res-Q point-of-care cell processing system from Celling Technologies

Celling Technologies, an innovator in stem cell therapy, launched its latest technology for the isolation of adult stem cells. The Res-Q device was developed by ThermoGenesis Corporation to provide an easy to use, point-of-care system to compliment their MXP system currently being marketed in the United States and several international markets.

12 Oct 2009

Xoft to showcase a variety of investigational IORT oncology applications at ACS Annual Congress

Clinical experience with the FDA cleared Axxent® Electronic Brachytherapy, eBx(TM), System from Xoft shows promise for the multi-disciplinary use of the isotope-free cancer treatment platform to deliver intraoperative radiation therapy (IORT). Xoft will showcase a variety of investigational IORT oncology applications at the American College of Surgeons 95th Annual Clinical Congress here in Chicago, October 11-15, 2009.

12 Oct 2009

Medical liability reform to save $54 billion over 10 years

The nation’s neurosurgeons are urging lawmakers to pay close attention to the newly released findings of the nonpartisan Congressional Budget Office (CBO) which confirm that medical liability reform does indeed reduce the use of healthcare services and will save the system money. In an October 9, 2009 letter to Senator Orrin G. Hatch (R-UT), CBO Director Douglas W. Elmendorf stated that a comprehensive set of tort reforms will reduce the nation’s deficit by $54 billion over 10 years.

12 Oct 2009

First-quarter fiscal 2010 results announced by Biomet

Biomet, Inc. announced today financial results for its first fiscal quarter ended August 31, 2009.

9 Oct 2009

TOPS Versalink Spinal System to treat moderate to severe lumbar stenosis

Impliant, Inc., a developer of novel motion-sparing alternatives to traditional spinal fusion surgery, announced today that it conducted the first two implantations of its TOPS VersaLink System, the newest addition to its product portfolio.

9 Oct 2009

Ethnicity plays a significant role in non-small cell lung cancer genetics: Study

Clinical research out of University Hospitals Case Medical Center has found that African Americans with a common form of lung cancer have a lower frequency of drug-sensitizing genetic mutations, which may impact response to new cancer-fighting drugs.

8 Oct 2009

Misonix signs exclusive distribution agreement with Neurotechnics

Misonix, Inc., a developer of minimally invasive ultrasonic medical device technology, which in Europe is used for the ablation of tumors and worldwide for other acute health conditions, has entered into a new, three year, exclusive distribution agreement with Neurotechnics Ltd., based in Banbury, England, for the distribution of the BoneScalpel(TM) Ultrasonic Bone Cutter.

8 Oct 2009

US Spine introduces Phantom Plus Interbody Fusion System

US Spine® is pleased to announce the launch of the Phantom Plus™ Interbody Fusion System. Phantom Plus provides spine surgeons with next generation instrumentation and implants that offer a compliment to US Spine’s posterior fixation systems. Features include tapered leading edges for easy insertion, a higher degree of doming to more closely match endplate anatomy, anti-migration teeth, and advanced instrumentation for multiple insertion techniques.

7 Oct 2009

AAAHC accreditation for Laser Spine Institute Tampa

Laser Spine Institute, leaders in minimally invasive spinal surgery, is pleased to announce the accreditation of LSI Tampa by the Accreditation Association for Ambulatory Health Care.

6 Oct 2009

Spinal fusion dynamic stabilization system manufacturers ordered to conduct postmarket surveillance studies

The U.S. Food and Drug Administration today ordered manufacturers of certain types of pedicle screw systems, called dynamic stabilization systems, to conduct postmarket surveillance studies to collect clinical data on a number of potential safety issues, including fusion rates and frequency of additional surgeries.

6 Oct 2009

$Hip fracture patients more likely to be evaluated for osteoporosis than wrist fracture patients$

Hip fracture patients more likely to be evaluated for osteoporosis than wrist fracture patients

A study published in the October 2009 issue of the Journal of Bone and Joint Surgery suggests a disconnect between the way wrist-fracture patients and those with a spine or hip fracture are managed and evaluated. The study, conducted in 2007 among 97 percent of the women in Korea, reviewed the incidence of fractures around the hip, spine, and wrist in female patients age 50 and older and the prescription frequencies of bone density scans for osteoporosis, along with the use of medications for its treatment.

3 Oct 2009

University HealthSystem Consortium awards UH Case Medical Center the 2009 Quality Leadership Award

University Hospitals (UH) Case Medical Center is one of five academic medical centers in the nation to receive the 2009 Quality Leadership Award from the University HealthSystem Consortium (UHC). The prestigious award is given to teaching hospitals that demonstrate excellence in delivering high-quality care, as measured by the UHC Quality and Accountability Study conducted annually since 2005.

3 Oct 2009

Six hospitals to pay $8 million to Medicare to settle allegations of false claims

Six hospitals in Indiana and Alabama have agreed to pay the United States more than $8 million to settle allegations that the health care facilities submitted false claims to Medicare, the Department of Justice announced today.

3 Oct 2009

ETEX' Equivabone receives additional FDA clearance for use in posterolateral spine fusion

ETEX Corporation, an advanced biomaterials company, announced today additional FDA 510(k) cleared indications for EquivaBone®. EquivaBone was the first FDA cleared hard-setting osteoinductive material and is the only osteoinductive bone graft substitute that provides a continuous nanocrystalline calcium phosphate scaffold.

3 Oct 2009

Clinical study results of prostate cancer patients treated with CyberKnife Radiosurgery released

Accuray Incorporated, a global leader in the field of radiosurgery, announced today publication of results from a study of early stage prostate cancer patients treated with CyberKnife Radiosurgery.

1 Oct 2009

Spine News and Research

Endoscopic surgery reduces postoperative discomfort and recovery time

FONAR sells two more UPRIGHT Multi-Position MRI scanners

Johnson & Johnson announces financial results for the third quarter of 2009

SANUWAVE presents findings on extracorporeal shock wave stimulation of osteoprogenitor cells

FDA clears RSB Spine's Interplate C-Ti as an anterior cervical plate

Res-Q point-of-care cell processing system from Celling Technologies

Xoft to showcase a variety of investigational IORT oncology applications at ACS Annual Congress

Medical liability reform to save $54 billion over 10 years

First-quarter fiscal 2010 results announced by Biomet

TOPS Versalink Spinal System to treat moderate to severe lumbar stenosis

Ethnicity plays a significant role in non-small cell lung cancer genetics: Study

Misonix signs exclusive distribution agreement with Neurotechnics

US Spine introduces Phantom Plus Interbody Fusion System

AAAHC accreditation for Laser Spine Institute Tampa

Spinal fusion dynamic stabilization system manufacturers ordered to conduct postmarket surveillance studies

Hip fracture patients more likely to be evaluated for osteoporosis than wrist fracture patients

University HealthSystem Consortium awards UH Case Medical Center the 2009 Quality Leadership Award

Six hospitals to pay $8 million to Medicare to settle allegations of false claims

ETEX' Equivabone receives additional FDA clearance for use in posterolateral spine fusion

Clinical study results of prostate cancer patients treated with CyberKnife Radiosurgery released

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News